Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of decitabine and valproic acid
in treating patients with non-small cell lung cancer. Drugs used in chemotherapy, such as
decitabine and valproic acid, work in different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.